Input CIK:

Show Other Options & Instructions

Owned(%):
Shares Outstanding(‱):
Transaction Code:

Instructions

Month Back: Display transaction record of previous n months.

Owned(%): Transaction shares relative to shares owned.

Shares Outstanding(‱): Transaction shares relative to shares outstanding.

Check Insider Trading (Reporter) for more details.

FOSTER-CHEEK KAYE I 1312622 Data last updated 2024-05-11 06:58:14 -0500 US CDT

Latest Holdings

Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.

3M 6M 1Y 2Y MAX

Non-derivative Transactions     CSV download

Tips: type "code_s" to show transactions with code "S".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-06-23 2023-06-21 2023-06-21 4 Foster Cheek Kaye I DIRECTOR acq 4975.0 43.17 0.9 0.0 Direct Common Stock AGIOS PHARMACEUTICALS, INC.

code_M

code  M 		11524.0 55.58 (AGIO)
2023-06-23 2023-06-21 4 Foster Cheek Kaye I DIRECTOR holding 2200.0 0 0.4 0.0 By Foster Family Revocable Trust Common Stock AGIOS PHARMACEUTICALS, INC.

code_

NA 		55.58 (AGIO)
2023-08-11 2023-08-09 4 Foster Cheek Kaye I DIRECTOR holding 2200.0 0 0.39 0.0 By Foster Family Revocable Trust Common Stock AGIOS PHARMACEUTICALS, INC.

code_

NA 		55.74 (AGIO)
2023-08-11 2023-08-09 2023-08-09 4 Foster Cheek Kaye I DIRECTOR dsp 25000.0 68.45 4.49 25.96 Direct Common Stock AGIOS PHARMACEUTICALS, INC.

code_S

code  S 		11524.0 55.74 (AGIO)
2023-08-11 2023-08-09 2023-08-09 4 Foster Cheek Kaye I DIRECTOR acq 25000.0 68.45 4.49 18.09 Direct Common Stock AGIOS PHARMACEUTICALS, INC.

code_M

code  M 		36524.0 55.74 (AGIO)
2024-03-07 2024-03-05 4 Foster Cheek Kaye I DIRECTOR holding 2200.0 0 0.39 0.0 By Foster Family Revocable Trust Common Stock AGIOS PHARMACEUTICALS, INC.

code_

NA 		56.19 (AGIO)
2024-03-07 2024-03-05 2024-03-05 to 2024-03-06 4 Foster Cheek Kaye I DIRECTOR dsp 4715.0 40.91 0.84 32.0 Direct Common Stock AGIOS PHARMACEUTICALS, INC.

code_S

code  S 		6809.0 thumbnail 56.19 (AGIO)
2024-03-11 2024-03-07 4 Foster Cheek Kaye I DIRECTOR holding 2200.0 0 0.39 0.0 By Foster Family Revocable Trust Common Stock AGIOS PHARMACEUTICALS, INC.

code_

NA 		56.19 (AGIO)
2024-03-11 2024-03-07 2024-03-07 4 Foster Cheek Kaye I DIRECTOR dsp 1285.0 18.87 0.23 31.62 Direct Common Stock AGIOS PHARMACEUTICALS, INC.

code_S

code  S 		5524.0 56.19 (AGIO)

Derivative Transactions

Tips: type "code_m" to show transactions with code "M".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-06-15 2023-06-13 2023-06-13 4 Foster Cheek Kaye I DIRECTOR acq 3388.0 100.0 0.61 0.0 Direct Restricted Stock Units AGIOS PHARMACEUTICALS, INC.

code_A

code  A 		3388.0 55.58 (AGIO)
2023-06-15 2023-06-13 2023-06-13 4 Foster Cheek Kaye I DIRECTOR acq 18958.0 100.0 3.41 26.56 Direct Stock Options (Right To Buy) AGIOS PHARMACEUTICALS, INC.

code_A

code  A 		18958.0 55.58 (AGIO)
2023-06-16 2023-06-14 2023-06-14 4 Foster Cheek Kaye I DIRECTOR acq 39062.0 100.0 4.02 14.83 Direct Stock Option (Right To Buy) PRIME MEDICINE, INC.

code_A

code  A 		39062.0 97.23 (PRME)
2023-06-23 2023-06-21 2023-06-21 4 Foster Cheek Kaye I DIRECTOR dsp 4975.0 100.0 0.9 0.0 Direct Restricted Stock Unit AGIOS PHARMACEUTICALS, INC.

code_M

code  M 		0.0 55.58 (AGIO)
2023-08-11 2023-08-09 2023-08-09 4 Foster Cheek Kaye I DIRECTOR dsp 25000.0 85.3 4.49 18.09 Direct Stock Options (Right To Buy) AGIOS PHARMACEUTICALS, INC.

code_M

code  M 		4307.0 55.74 (AGIO)

a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)